SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 166 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 2.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,278,000 | -86.8% | 1,200,000 | -67.6% | 0.68% | -85.3% |
| Q2 2023 | $77,625,979 | -0.9% | 3,708,838 | 0.0% | 4.64% | -18.3% |
| Q1 2023 | $78,330,659 | -17.0% | 3,708,838 | 0.0% | 5.67% | -3.4% |
| Q4 2022 | $94,389,927 | +15.1% | 3,708,838 | +8.7% | 5.87% | -7.1% |
| Q3 2022 | $82,010,000 | +33.4% | 3,412,838 | +6.8% | 6.32% | +8.8% |
| Q2 2022 | $61,480,000 | +10.7% | 3,195,403 | 0.0% | 5.80% | +22.6% |
| Q1 2022 | $55,536,000 | – | 3,195,403 | – | 4.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 956,165 | $20,930,000 | 11.19% |
| Aisling Capital Management LP | 1,025,000 | $22,437,000 | 7.92% |
| FRAZIER MANAGEMENT LLC | 2,772,062 | $60,680,000 | 4.67% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,176,585 | $25,755,000 | 2.83% |
| Paradigm Biocapital Advisors LP | 453,091 | $9,918,000 | 2.83% |
| Ghost Tree Capital, LLC | 300,000 | $6,567,000 | 2.35% |
| Avidity Partners Management LP | 4,823,400 | $105,584,000 | 2.24% |
| Nantahala Capital Management | 2,850,559 | $62,399,000 | 2.20% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $4,512,000 | 1.90% |
| BVF INC/IL | 2,099,714 | $45,963,000 | 1.67% |